Androgen receptor mutation and progression of prostate cancer.
- Author:
Jian-Guo MA
1
;
Wen-Ping LI
;
Yu-Qing JIANG
Author Information
1. Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.
- Publication Type:Journal Article
- MeSH:
Disease Progression;
Humans;
Male;
Mutation;
Prostatic Neoplasms;
genetics;
pathology;
Receptors, Androgen;
genetics
- From:
National Journal of Andrology
2011;17(7):649-654
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer growth is almost wholly dependent on the route of the androgen receptor and most therapies aimed at blocking this signaling axis are useful tools in the management of this disease. Unfortunately such therapies invariably fail, and the cancer progresses to an androgen-independent stage. In such cases, androgen receptor mutation almost always occurs and much evidence suggests the continuous growth of the tumor. One mechanism by which the receptor is thought to remain active is mutation. This paper reviews the molecular mechanism of tumor growing after androgen receptor mutation and some of the promising management principles and systemic chemotherapy options against prostate cancer.
